tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ENTX Stock Latest News

Entera Bio announces open market purchases of stock by board members
The FlyEntera Bio announces open market purchases of stock by board members
9d ago
ENTX
Entera Bio Names Geno Germano Independent Board Chairman
PremiumCompany Announcements
Entera Bio Names Geno Germano Independent Board Chairman
11d ago
8K
ENTX
Entera Bio appoints Geno Germano as chairman of the board
PremiumThe Fly
Entera Bio appoints Geno Germano as chairman of the board
11d ago
PFE
ENTX
Entera Bio Expands OPKO Partnership, Adds New Director
PremiumCompany Announcements
Entera Bio Expands OPKO Partnership, Adds New Director
16d ago
8K
ENTX
Opko Health Entera Bio, Entera Bio expand partnership to advance PTH tablet
PremiumThe Fly
Opko Health Entera Bio, Entera Bio expand partnership to advance PTH tablet
16d ago
OPK
ENTX
Entera Bio announces expected milestones for Q1 in 2026
PremiumThe FlyEntera Bio announces expected milestones for Q1 in 2026
1M ago
ENTX
Entera Bio ‘congratulates’ FNIH-ASBMR-SABRE team on FDA endpoint qualification
Premium
The Fly
Entera Bio ‘congratulates’ FNIH-ASBMR-SABRE team on FDA endpoint qualification
2M ago
ENTX
Entera Bio announces new data on long-acting PTH tablet
Premium
The Fly
Entera Bio announces new data on long-acting PTH tablet
2M ago
ENTX
Entera Bio Reports Q3 2025 Financial Results
PremiumCompany Announcements
Entera Bio Reports Q3 2025 Financial Results
3M ago
ENTX
Entera Bio Reports Q3 2025 Results and FDA Agreement
PremiumCompany Announcements
Entera Bio Reports Q3 2025 Results and FDA Agreement
3M ago
8K
ENTX
Entera Bio presents clinical data from EB613 Phase 2 trial
PremiumThe Fly
Entera Bio presents clinical data from EB613 Phase 2 trial
4M ago
ENTX
Entera Bio’s Promising Oral Therapies Drive Buy Rating: Analyst Highlights Developments in GLP-2 and EB613 Programs
PremiumRatings
Entera Bio’s Promising Oral Therapies Drive Buy Rating: Analyst Highlights Developments in GLP-2 and EB613 Programs
5M ago
ENTX
Entera Bio announces presentation of PK data for GLP-2 tablet treatment
PremiumThe FlyEntera Bio announces presentation of PK data for GLP-2 tablet treatment
5M ago
ENTX
Entera Bio presents data on EB613 in post-menopausal women with osteoporosis
Premium
The Fly
Entera Bio presents data on EB613 in post-menopausal women with osteoporosis
6M ago
ENTX
Entera Bio to present data across three oral peptide programs
Premium
The Fly
Entera Bio to present data across three oral peptide programs
6M ago
ENTX
Entera Bio’s Promising Phase 3 Study and Market Potential Drive Buy Rating
PremiumRatings
Entera Bio’s Promising Phase 3 Study and Market Potential Drive Buy Rating
6M ago
ENTX
Entera Bio Reports Q2 2025 Financial Results and Strategic Progress
PremiumCompany Announcements
Entera Bio Reports Q2 2025 Financial Results and Strategic Progress
7M ago
ENTX
Entera Bio Reports Q2 2025 Financial Results
PremiumCompany Announcements
Entera Bio Reports Q2 2025 Financial Results
7M ago
8K
ENTX
Entera Bio Advances EB613 with FDA Approval
PremiumCompany Announcements
Entera Bio Advances EB613 with FDA Approval
7M ago
8K
ENTX
Entera Bio receives FDA agreement on BMD as primary endpoint for EB613 study
PremiumThe FlyEntera Bio receives FDA agreement on BMD as primary endpoint for EB613 study
7M ago
ENTX
Entera Bio Elects New Board Member at Annual Meeting
Premium
Company Announcements
Entera Bio Elects New Board Member at Annual Meeting
7M ago
8K
ENTX
Entera Bio announces data for EB613 to be presented at ASBMR 2025
Premium
The Fly
Entera Bio announces data for EB613 to be presented at ASBMR 2025
8M ago
ENTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >